CAS: 199463-33-7 - Revaprazan
Fórmula:C22H23FN4
InChI:InChI=1S/C22H23FN4/c1-14-15(2)24-22(25-19-10-8-18(23)9-11-19)26-21(14)27-13-12-17-6-4-5-7-20(17)16(27)3/h4-11,16H,12-13H2,1-3H3,(H,24,25,26)
Clave InChI:InChIKey=LECZXZOBEZITCL-UHFFFAOYSA-N
SMILES:FC1=CC=C(C=C1)NC=2N=C(C(=C(N2)C)C)N3CCC=4C=CC=CC4C3C
- Sinónimos:
- Revaprazan
- 4-(3,4-Dihydro-1-methyl-2(1H)-isoquinolinyl)-N-(4-fluorophenyl)-5,6-dimethyl-2-pyrimidinamine
- YH 1885 free base
- 2-Pyrimidinamine, 4-(3,4-dihydro-1-methyl-2(1H)-isoquinolinyl)-N-(4-fluorophenyl)-5,6-dimethyl-
- SB 641257
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
Revaprazan REF: IN-DA00BHJSCAS: 199463-33-7 | 99% | A consultar | Mar 10 Dic 24 | |
Revaprazan REF: TM-T20660CAS: 199463-33-7 | 98% | 1.418,00 €~2.325,00 € | Lun 16 Dic 24 | |
Revaprazan REF: 3D-ZHA46333CAS: 199463-33-7 | Min. 95% | A consultar | Mar 21 Ene 25 |
Ref: IN-DA00BHJS
5mg | 121,00 € | ||
25mg | 306,00 € | ||
100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 10 de Diciembre de 2024
Revaprazan
CAS:199463-33-7
Revaprazan: novel, K⁺-competitive acid blocker; reversibly halts gastric H⁺/K⁺-ATPase; rivals PPIs in acid reduction.
Fórmula:
C22H23FN4
Pureza:
98%
Forma y color:
Solid
Peso molecular:
362.44
Ref: TM-T20660
25mg | 1.418,00 € | ||
50mg | 1.832,00 € | ||
100mg | 2.325,00 € |
Entrega estimada en Estados Unidos, el Lunes 16 de Diciembre de 2024
Revaprazan
CAS:199463-33-7
Revaprazan hydrochloride is the salt form of Revaprazan which is concentrated in the gastric parietal …
Fórmula:
C22H23FN4
Pureza:
Min. 95%
Peso molecular:
362.4 g/mol
Ref: 3D-ZHA46333
50mg | A consultar | ||
100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025